01—Abstract
Summary
Summary of the 8-K filed July 7, 2025. Cited figures are marked; the original filing is the authoritative source.
On July 7, 2025, CoreWeave (CRWV) announced a definitive merger agreement to acquire Core Scientific (CORZ) in an all-stock transaction.
Core Scientific stockholders will receive 0.1235 newly issued CoreWeave Class A shares for each CORZ share. The filing values the deal at approximately $9.0 billiona on a fully diluted basis, implying $20.40 per CORZ share based on CoreWeave's price as of July 3, 2025. That is a premium of about 66% to Core Scientific's unaffected closing price of $12.30 on June 25, 2025.
Management frames the deal as vertical integration: CoreWeave would own the data center infrastructure it currently leases, gaining about 1.3 GW of gross power and an incremental 1 GW+ of potential expansion capacity. The main financial rationale is the elimination of lease overhead. The company cites more than $10 billionb of cumulative future lease payments over the next 12 years on existing contractual sites, plus an estimated $500 million of fully ramped annual run-rate cost savings by the end of 2027.
Management also expects the deal to be leverage-neutral while giving CoreWeave access to infrastructure financing that could lower its overall cost of capital. Core Scientific's current stockholders would hold less than 10%c of the combined company after closing. The transaction is expected to close in Q4 2025, subject to regulatory approval and approval by Core Scientific stockholders.
The filing is a Regulation FD disclosure furnished under Item 7.01, and it contains extensive forward-looking-statement caveats covering integration risk, financing conditions, dilution, and development delays at conversion sites. Investors should note that this analysis reflects only the July 2025 filing and does not account for any later developments in the deal's status or terms.
02—Key points
Key Highlights
- All-stock merger at a fixed exchange ratio of 0.1235 CoreWeave Class A shares per Core Scientific share, implying about $20.40 per CORZ share and a total equity value of roughly $9.0 billion (fully diluted, based on CoreWeave's 5-day VWAP).
- The offer represents a premium of approximately 66% to Core Scientific's unaffected share price of $12.30 (June 25, 2025).
- CoreWeave would gain about 1.3 GW of gross power (about 840 MW supporting existing HPC contracts and about 500 MW of crypto mining capacity) plus an incremental 1 GW+ of potential power for expansion.
- Immediate elimination of more than $10 billion of cumulative future lease overhead over the next 12 years on existing contractual sites.
- Estimated $500 million of fully ramped annual run-rate cost savings by end of 2027, including the lease-overhead elimination.
- Management expects the deal to be leverage-neutral and to open access to more diverse, lower-cost infrastructure financing.
- Expected close in Q4 2025, subject to regulatory approval and Core Scientific stockholder approval; Core Scientific holders will own under 10% of the combined company. CoreWeave may repurpose sites toward HPC or divest the crypto mining business over the medium term.
03—Questions
Frequently Asked Questions
What is the deal, and how much is it worth?
CoreWeave will acquire Core Scientific in an all-stock transaction. Core Scientific holders receive 0.1235 CoreWeave Class A shares per CORZ share. The filing puts the total equity value at roughly $9.0 billion on a fully diluted basis, or about $20.40 per CORZ share at CoreWeave's July 3, 2025 price. The final value will depend on CoreWeave's share price at closing.
Why is CoreWeave acquiring Core Scientific?
The stated rationale is vertical integration of data center infrastructure. CoreWeave is currently a lessee at many Core Scientific sites. Owning them would eliminate more than $10 billion of future lease payments, reduce costs (about $500 million of run-rate savings by 2027), secure about 1.3 GW of power with 1 GW+ of expansion potential, and allow infrastructure-level financing that could lower the cost of capital.
How will the deal affect CoreWeave's balance sheet and dilution?
Management says the transaction is leverage-neutral to CoreWeave. Because it is all-stock, it causes dilution: Core Scientific holders would own less than 10% of the combined company after closing. The filing does not provide a detailed pro forma capital structure, and the forward-looking statements flag the risk that the deal could cost more than anticipated.
What could prevent the deal from closing?
Closing depends on customary conditions, including regulatory approvals and approval by Core Scientific stockholders. The filing also cites risks such as financing and rating-agency actions, business disruption or customer changes during the pendency period, integration challenges, potential litigation, and development delays as sites convert from crypto mining to HPC use.
When is the transaction expected to close, and what should investors watch next?
The companies expect closing in Q4 2025. Investors should watch for the Form S-4 registration statement and proxy statement/prospectus, the Core Scientific stockholder vote, antitrust and other regulatory clearances, and any updates to the exchange ratio, synergy targets, or financing plans. The exchange ratio is fixed, so the dollar value will move with CoreWeave's share price.
04—Continue